Follow us:

News & events

  • Home
  • News & informations
  • PRESS RELEASE : Ypso-Facto is part of the CALIPSO project led by Sanofi, to disrupt the production of biomedicines!

PRESS RELEASE : Ypso-Facto is part of the CALIPSO project led by Sanofi, to disrupt the production of biomedicines!

Supported by Bpifrance, the CALIPSO project aims at developing a new generation of tools that will disrupt industrial bioproduction processes.

  • by Ypso-Facto
  • September 16, 2021
PRESS RELEASE : Ypso-Facto is part of the CALIPSO project led by Sanofi, to disrupt the production of biomedicines!

 Nancy, France, 16 Sept 2021 - Ypso-Facto is proud to play a major role in this challenging and exciting project. With its expertise in bioprocesses and predictive simulation, Ypso-Facto will develop software solutions to support production of innovative therapies.

The company will work on three software tools that will allow:

  • to visualize and analyse research and production data in order to extract meaningful information for rational decision-making;
  • the predictive simulation of fermentation and cell culture bioreactors;
  • the predictive simulation of affinity chromatography, ion exchange or hydrophobic interaction purification systems.

These software tools will help accelerating process development time, improving productivity and minimizing environmental impact. Ypso-Facto is committed to support the bioproduction sector to deliver constantly improving processes.

 For more information, download the pdf below or contact us : contact@ypso-facto.com 



Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information